Skip to content

The random controlled trial of acupuncture in the treatment of polycystic ovary syndrome patients with insulin eesistance

The random controlled trial of acupuncture in the treatment of polycystic ovary syndrome patients with insulin eesistance

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003621
Enrollment
Unknown
Registered
2013-09-23
Start date
2013-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovarian sympton

Interventions

1:acupuncture protocol 1
2:acupuncture protocol 2

Sponsors

Suzhou City Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 18 to 35 years; 2. Diagnosis of PCOS: oligomenorrhea or amenorrhea (less than 8 cycles per year) and in line with one of the following conditionsclinical presentation or biochemical presentation of hyper-androgenemia, or ovarian polycystic changes by ultrasound B examination; 3. BMI>23.

Exclusion criteria

Exclusion criteria: 1. take the medicine which affects the outcome in the past 3 month, such as the contraceptives or other hormone drugs, insulin sensitizing agents, lipid-lowering drugs etc.; 2. other hyperandrogen related diseases (including 21 hydroxylase deficiency of congenital adrenal hyperplasia, androgen secreting tumors, excessive use of androgen production of drugs, Cushing syndrome, severe insulin resistance, thyroid dysfunction and hyperprolactinemia); 3. heart, liver, kidney and other important organic lesions or patients with mental disorders or the patients who can not cooperate with the treatment in study; 4. to be treated by using acupuncture for the condition in past 6 months; 5. have had fertility requirements in past 6 months.

Design outcomes

Primary

MeasureTime frame
testosterone;estrogen concentration;FSH;LH;PRL;progesterone;fasting blood glucose;insulin;C peptide;glycated hemoglobin;triglyceride;gigh density lipoprotein;low density lipoprotein;total cholesterol;ultrasound;androstenedione;17- hydroxyprogesterone;dehydroepiandrosterone sulfate;sex hormone binding globuli;

Secondary

MeasureTime frame
height;weight;BMI;hip;waistline;blood pressure;pulse;Rate of respiration;hirsutism score;acne;acanthosis nigrican;

Countries

China

Contacts

Public ContactXiaofeng Xu

Suzhou City Hospital of Traditional Chinese Medicine

xxf196308@sina.com+86 18951106882

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026